UK Renal Registry 12th Annual Report (December 2009): chapter 6: comorbidities and current smoking status amongst patients starting renal replacement therapy in England, Wales and Northern Ireland from 2003 to 2008: national and centre-specific analyses.
BACKGROUND
The prevalence of comorbidities in incident renal replacement therapy (RRT) patients changes with age and varies between ethnic groups. This study describes these associations and the independent effect of comorbidities on outcomes.


METHODS
Adult patients starting RRT between 2003 and 2008 in centres reporting to the UK Renal Registry (UKRR) with data on comorbidity (n (1/4) 14,909) were included. The UKRR studied the association of comorbidity with patient demographics, treatment modality, haemoglobin, renal function at start of RRT and subsequent listing for kidney transplantation. The relationship between comorbidities and mortality at 90 days and one year after 90 days from start of RRT was explored using Cox regression.


RESULTS
Completeness of comorbidity data was 40.0% compared with 54.3% in 2003. Of patients with data, 53.8% had one or more comorbidities. Diabetes mellitus and ischaemic heart disease were the most common conditions seen in 30.1% and 22.7% of patients respectively. Current smoking was recorded for 14.5% of incident RRT patients in the 6-year period. Comorbidities became more common with increasing age in all ethnic groups although the difference between the 65-74 and 75+ age groups was not significant. Within each age group, South Asians and Blacks had lower rates of comorbidity, despite higher rates of diabetes mellitus. In multivariate survival analysis, malignancy and ischaemic/neuropathic ulcers were the strongest independent predictors of poor survival at 1 year after 90 days from the start of RRT.


CONCLUSIONS
Differences in prevalence of comorbid illnesses in incident RRT patients may reflect variation in access to health care or competing risk prior to commencing treatment. At the same time, smoking rates remained high in this 'at risk' population. Further work on this and ways to improve comorbidity reporting should be priorities for 2010-11.
Caskey
Fergus
F
UK Renal Registry, Southmead Hospital, Bristol, UK. fergus.caskey@nbt.nhs.uk
Webb
Lynsey
L
Gilg
Julie
J
Fogarty
Damian
D
D000293:Adolescent; D000328:Adult; D000368:Aged; D000847:Annual Reports as Topic; D015897:Comorbidity; D003920:Diabetes Mellitus / Q000453:epidemiology / Q000628:therapy; D004739:England / Q000453:epidemiology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D015337:Multicenter Studies as Topic / Q000639:trends*; D017202:Myocardial Ischemia / Q000453:epidemiology / Q000628:therapy; D009660:Northern Ireland / Q000453:epidemiology; D012042:Registries; D051437:Renal Insufficiency / Q000453:epidemiology* / Q000628:therapy; D017582:Renal Replacement Therapy / Q000639:trends*; D012907:Smoking / Q000453:epidemiology* / Q000639:trends; D006113:United Kingdom / Q000453:epidemiology; D014852:Wales / Q000453:epidemiology; D055815:Young Adult